Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,382 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07092761Recruiting
Testing a new continuous glucose monitor
This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.
Luoyang, HenanAges 18 years+ - NCT07171164Recruiting
Community-based ways to boost RSV vaccine use in Latino adults
This study looks at community-based ways to help Latino adults ages 50 and older in San Francisco and Daly City get the RSV vaccine. The goal is to learn what works best to increase vaccination rates.
San Francisco, CaliforniaAges 18 years+ - NCT07133477Recruiting
Fish oil for skin health
This study tests whether taking fish oil concentrate can improve skin function in adults who have sensitive, redness-prone skin. If you're between 35 and 65 and have skin that easily gets dry or red, this might be a good fit.
CardiffAges 35–65 - NCT07110038RecruitingPhase 2
Study of Enfortumab Vedotin Plus Avelumab for Advanced Penile Cancer
This trial tests a combination of two drugs (enfortumab vedotin and avelumab) as a first treatment for men with advanced or metastatic penile cancer that cannot be removed by surgery. The goal is to see if this new combination can shrink tumors and improve outcomes.
DresdenAges 18 years+ - NCT07179497Recruiting
Study of Neobone in dental bone surgery
This study looks at how safe and effective Neobone is for repairing bone in dental surgery. If you need a bone graft for your jaw or teeth, this could be relevant.
LisbonAges 18 years+ - NCT07063069Recruiting
Using ultrasound to prevent nausea after abdominal surgery
This study uses a quick ultrasound of your stomach to predict if you will feel sick or vomit after major abdominal surgery. It helps doctors give you the right medicine to prevent nausea.
AngersAges 18 years+ - NCT07029282RecruitingPhase 3
Vitamin supplement study for pregnant women and new moms
This trial tests a special vitamin supplement (MMSPlus) given before and after birth to improve baby growth. Pregnant women with a healthy single baby can join, and then continue after birth if they plan to breastfeed.
Karachi, SindhAges 15–49 - NCT06330064RecruitingPhase 1/Phase 2
Study of a new drug for advanced solid tumors
This study tests a new drug called Ifinatamab Deruxtecan (I-DXd) for people with several types of advanced cancer that has grown despite standard treatments. The drug is designed to target and attack cancer cells directly, potentially shrinking tumors or slowing their growth.
Los Angeles, CaliforniaAges 18 years+ - NCT07529704Recruiting
Early help for healthy weight in young children
This trial tests a program to help families with young children build healthy habits and prevent obesity. It focuses on families facing challenges like low income or housing issues.
Burgos, Castille and LeónAges Any age - NCT07729839RecruitingPhase 1
Study of ADB116 injection for healthy volunteers
This trial tests a new medicine called ADB116 in healthy people to see how safe it is and how the body processes it. The results will help decide the right dose for future studies.
Guangzhou, GuangdongAges 18–45 - NCT06084936RecruitingPhase 3
Glofitamab alone vs other treatments for mantle cell lymphoma
This trial tests a new drug called glofitamab to see if it works better than other standard treatments for people with mantle cell lymphoma that has come back or not responded to previous therapy. It is for patients who have already tried a BTK inhibitor and at least one other treatment.
Berkeley, CaliforniaAges 18 years+ - NCT06869967Recruiting
Pain Control After Ear Surgery (Mastoidectomy)
This study tests a pain-blocking injection to reduce pain after a specific type of ear surgery (mastoidectomy). It may help you feel less pain after your operation.
IstanbulAges 18 years+ - NCT07399171RecruitingPhase 2
Testing HT-4253 to prevent Alzheimer's in APOE4 carriers
This trial tests an experimental drug called HT-4253 to see if it can prevent Alzheimer's disease in people who are at higher genetic risk (carry the APOE4 gene) and have early signs of amyloid buildup in the brain. If you qualify, you would take the drug or a placebo and be monitored over time.
Abu Dhabi, Abu Dhabi EmirateAges 50–75 - NCT05826743Recruiting
Check a new alternative to ileostomy after bowel surgery
This trial tests whether a device called COLO-BT can be a safer, effective alternative to an ileostomy (a temporary or longer-term opening from the intestine to the skin). It’s for certain adults having a bowel connection low in the pelvis, where leak risk matters.
Buffalo, New YorkAges 19–80 - NCT07287670RecruitingPhase 2
Testing MTX-474 for diffuse scleroderma
This trial tests an investigational drug called MTX-474 for people with diffuse cutaneous systemic sclerosis (a type of scleroderma that affects the skin and internal organs). The study aims to see if it can help slow or improve skin thickening and other symptoms.
Phoenix, ArizonaAges 18 years+ - NCT05039619RecruitingPhase 2
Obinutuzumab trial for adolescents with active lupus kidney inflammation
This Phase 2 study tests obinutuzumab, a targeted antibody medicine, in teens with active lupus nephritis (inflammation in the kidney). It looks at whether it helps kidney disease and is safe, including how the body handles the drug.
Loma Linda, CaliforniaAges 5–17 - NCT06872125RecruitingPhase 3
Testing zorevunersen for Dravet syndrome
This study tests an experimental drug called zorevunersen for people with Dravet syndrome. It aims to see if the drug can reduce seizures and improve safety.
Phoenix, ArizonaAges 2–17 - NCT07614477RecruitingPhase 2
Testing EVER001 for kidney protein-loss diseases
This study tests a new drug called EVER001 to see if it can reduce protein loss in urine and improve kidney function in patients with specific kidney diseases (FSGS, MCD, or IgAN). These are autoimmune kidney conditions that cause the kidneys to leak protein into the urine.
Beijing, Beijing MunicipalityAges 18–75 - NCT07614867Recruiting
Group therapy for emotion control in adults with ADHD
This study tests whether group-based cognitive behavioral therapy (a type of talk therapy) can help adults with ADHD who struggle to manage their emotions. You would attend sessions with others facing similar challenges to learn practical emotion-regulation skills.
StockholmAges 18 years+ - NCT07695818Recruiting
Land-based program for young parents to prevent substance misuse
This trial tests a program called Returning to the Land, which helps young parents aged 14-19 who live near the Rocky Boy Reservation. The goal is to see if connecting with land and culture can reduce substance misuse and support healthy families.
Box Elder, MontanaAges 14–19 - NCT07281833RecruitingPhase 3
Testing capivasertib with hormone therapy for advanced breast cancer
This trial tests a new oral drug called capivasertib combined with standard hormone therapy for people with advanced breast cancer that is HR-positive and HER2-negative. It is for those whose cancer has progressed on previous hormone therapy and who have a specific gene change (PIK3CA, AKT1, or PTEN).
AnderlechtAges 18 years+ - NCT07103200Recruiting
Decision-making fatigue after traumatic brain injury
This study looks at how making decisions can feel more tiring after a mild or moderate traumatic brain injury compared to people without a brain injury. It uses computer tasks to measure fatigue.
Minneapolis, MinnesotaAges 18 years+ - NCT06419374RecruitingPhase 3
Testing a new drug for liver scarring from MASH
This trial tests a new drug called pegozafermin to see if it can help people with cirrhosis (scarring) of the liver caused by MASH (a fatty liver disease). If you have cirrhosis and either diabetes or multiple risk factors, this study might be an option for you.
Birmingham, AlabamaAges 18–75 - NCT06412120RecruitingPhase 4
Niraparib safety and metabolism study in Black women
This trial tests a new maintenance therapy called niraparib for Black women who have finished initial treatment for advanced ovarian cancer and are in remission or partial response. It aims to see if the drug is safe and how your body processes it.
Fort Lauderdale, FloridaAges 18 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,382 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.